An Overview of High-Efficacy Drugs for Multiple Sclerosis: Gulf Region Expert Opinion

This article discusses the opinions of the multiple sclerosis (MS) experts in the Gulf region on the use of high-efficacy disease-modifying drugs (DMDs; natalizumab, fingolimod, alemtuzumab, cladribine tablets, and ocrelizumab) in clinical practice. The experts reviewed the current literature includ...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurol Ther
Main Authors: Alroughani, Raed, Inshasi, Jihad Said, Deleu, Dirk, Al-Hashel, Jasem, Shakra, Mustafa, Elalamy, Osama Robin, Shatila, Ahmed Osman, Al-Asmi, Abdullah, Al Sharoqi, Isa, Canibano, Beatriz Garcia, Boshra, Amir
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Healthcare 2019
Assuntos:
Commentary
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6534637/
https://ncbi.nlm.nih.gov/pubmed/30875021
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40120-019-0129-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados